Scoggins Christopher J 4
4 · ABBOTT LABORATORIES · Filed Feb 25, 2020
Insider Transaction Report
Form 4
Scoggins Christopher J
EXECUTIVE VICE PRESIDENT
Transactions
- Award
Option (right to buy)
2020-02-21+68,578→ 68,578 totalExercise: $87.72From: 2021-02-21Exp: 2030-02-20→ Common shares (68,578 underlying) - Award
Common shares without par value
2020-02-21+11,250→ 44,828 total
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 22,859 on February 21, 2021, 22,859 on February 21, 2022, and 22,860 on February 21, 2023.